Despite an expanding dilemma in pet wellness and human medication, Niclosavir Limited gets on a goal to fight antimicrobial resistance (AMR) with cutting-edge options that repurpose an old Bayer medicine. This strong endeavor intends to change the therapy of bovine mastitis– among the leading sources of antibiotic usage in New Zealand’s dairy products industry.Driven by an experienced group with over 200 years of mixed experience, this Sprout Accelerator Spring24 endeavor is identified to leave a remedy …
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/meet-the-founder-niclosavir/
